Last updated: 14 June 2021 at 5:19pm EST

John Crues Net Worth




The estimated Net Worth of John V Crues is at least $32 Million dollars as of 15 March 2021. John Crues owns over 10,000 units of Radnet Inc stock worth over $27,116,823 and over the last 18 years he sold RDNT stock worth over $4,377,115. In addition, he makes $555,870 as Vice President, Medical Director, Director, and Corporate Secretary at Radnet Inc.

John Crues RDNT stock SEC Form 4 insiders trading

John has made over 21 trades of the Radnet Inc stock since 2007, according to the Form 4 filled with the SEC. Most recently he sold 10,000 units of RDNT stock worth $238,200 on 15 March 2021.

The largest trade he's ever made was exercising 250,000 units of Radnet Inc stock on 26 April 2010 worth over $180,000. On average, John trades about 23,353 units every 150 days since 2007. As of 15 March 2021 he still owns at least 435,262 units of Radnet Inc stock.

You can see the complete history of John Crues stock trades at the bottom of the page.





John Crues biography

Dr. John V. Crues III M.D. serves as Vice President, Medical Director, Director, Corporate Secretary of the Company. Dr. Crues received his M.D. at Harvard University, completed his internship at the University of Southern California in Internal Medicine, and completed a residency at Cedars-Sinai in Internal Medicine and Radiology. Dr. Crues has authored numerous publications while continuing to actively participate in radiological societies such as the Radiological Society of North America, American College of Radiology, California Radiological Society, International Society for Magnetic Resonance Medicine and the International Skeletal Society. Dr. Crues is also currently Co-President of Pronet Imaging Medical Group, a director of BRMG and owns a controlling interest in four medical groups which provide professional medical services at our imaging facilities located in New York, New York. Dr. Crues plays a significant role as a musculoskeletal specialist for many of our patients as well as a resource for physicians providing services at our facilities. His active participation in radiological societies gives our Board of Directors access to thought leadership in the field of radiology.

What is the salary of John Crues?

As the Vice President, Medical Director, Director, and Corporate Secretary of Radnet Inc, the total compensation of John Crues at Radnet Inc is $555,870. There are 10 executives at Radnet Inc getting paid more, with Howard Berger having the highest compensation of $3,048,400.



How old is John Crues?

John Crues is 69, he's been the Vice President, Medical Director, Director, and Corporate Secretary of Radnet Inc since 2019. There are 6 older and 14 younger executives at Radnet Inc. The oldest executive at Radnet Inc is Lawrence Levitt, 77, who is the Independent Director.

Insiders trading at Radnet Inc

Over the last 18 years, insiders at Radnet Inc have traded over $68,665,945 worth of Radnet Inc stock and bought 32,219 units worth $511,954 . The most active insiders traders include Norman R Hames, Sandy Nyholm Sandy Nyholm K..., and Mark Stolper. On average, Radnet Inc executives and independent directors trade stock every 26 days with the average trade being worth of $2,271,022. The most recent stock trade was executed by Michael N Murdock on 21 August 2024, trading 15,000 units of RDNT stock currently worth $941,700.



What does Radnet Inc do?

radnet, inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services in the united states based on the number of locations and annual imaging revenue. radnet has a network of 340+ owned and/or operated outpatient imaging centers. radnet's core markets include california, delaware, maryland, new jersey, and new york. together with affiliated radiologists, and inclusive of full-time and per diem employees and technicians, radnet has a total of approximately 7,300 employees.



What does Radnet Inc's logo look like?

Radnet Inc logo

Complete history of John Crues stock trades at Radnet Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
15 Mar 2021 John V Crues
Medical Director
Sale 10,000 $23.82 $238,200
15 Mar 2021
435,262
18 Nov 2019 John V Crues
Medical Director
Sale 20,000 $18.01 $360,200
18 Nov 2019
414,097
15 Nov 2019 John V Crues
Medical Director
Sale 20,000 $17.78 $355,600
15 Nov 2019
434,097
14 Nov 2019 John V Crues
Medical Director
Sale 20,000 $15.84 $316,800
14 Nov 2019
454,097
12 Aug 2019 John V Crues
Medical Director
Sale 50,000 $15.07 $753,500
12 Aug 2019
474,097
16 May 2019 John V Crues
Medical Director
Sale 20,000 $13.15 $263,000
16 May 2019
524,097
18 Sep 2018 John V Crues
Medical Director
Sale 10,000 $15.30 $153,000
18 Sep 2018
519,097
11 May 2018 John V Crues
Medical Director
Sale 15,000 $13.00 $195,000
11 May 2018
529,097
19 Dec 2017 John V Crues
Medical Director
Sale 19,684 $10.01 $197,037
19 Dec 2017
544,097
1 Dec 2017 John V Crues
Medical Director
Sale 20,000 $10.08 $201,600
1 Dec 2017
563,781
27 Nov 2017 John V Crues
Medical Director
Sale 20,000 $9.89 $197,800
27 Nov 2017
583,781
16 Nov 2017 John V Crues
Medical Director
Sale 40,000 $9.90 $396,000
16 Nov 2017
603,781
5 Jun 2015 John V Crues
Medical Director
Sale 10,000 $6.62 $66,200
5 Jun 2015
778,112
2 Jun 2015 John V Crues
Medical Director
Sale 15,000 $6.47 $97,050
2 Jun 2015
778,112
18 Aug 2014 John V Crues
Medical Director
Sale 16,667 $6.91 $115,169
18 Aug 2014
768,112
13 May 2014 John V Crues
Medical Director
Sale 16,667 $6.40 $106,669
13 May 2014
784,779
13 May 2010 John V Crues
Medical Director
Sale 50,000 $3.34 $167,000
13 May 2010
578,708
26 Apr 2010 John V Crues
Medical Director
Option 250,000 $0.72 $180,000
26 Apr 2010
673,262
10 Jan 2008 John V Crues
Medical Director
Sale 10,000 $9.51 $95,100
10 Jan 2008
423,262
4 Dec 2007 John V Crues
Medical Director
Sale 11,000 $9.29 $102,190
4 Dec 2007
770,719
5 Apr 2007 John V Crues
Medical Director
Option 150,000 $0.46 $69,000
5 Apr 2007
781,719


Radnet Inc executives and stock owners

Radnet Inc executives and other stock owners filed with the SEC include: